Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Richard A Proctor

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) infection has reached epidemic proportions, and therapeutic options are limited because these strains are often multidrug resistant. However, the new strains of community-acquired MRSA show decreased resistance to trimethoprim-sulfamethoxazole. Clinical and experimental reports show a mixture of successes and failures with trimethoprim-sulfamethoxazole treatment. A reason for failure might be the amount of thymidine released from damaged host tissues and bacteria, a concept strengthened by the fact that S. aureus thermonuclease releases thymidine from DNA. Thus, success or failure with trimethoprim-sulfamethoxazole may well depend on the amount of tissue damage and organism burden, rather than acquisition of a resistance gene. Clinical trials and experimental animal studies show high failure rates, perhaps because of released thymidine. The use of trimethoprim-sulfamethoxazole for community-acquired MRSA infection should not be endorsed without further research.

References

Feb 1, 1978·Journal of Clinical Pathology·A Stokes, R W Lacey
Jan 1, 1976·CRC Critical Reviews in Clinical Laboratory Sciences·W H Sperber
Jul 1, 1988·The Journal of Antimicrobial Chemotherapy·J M Hamilton-Miller
Dec 1, 1988·The Journal of Antimicrobial Chemotherapy·V YeldandiJ R Lentino
Nov 1, 1973·The Journal of Infectious Diseases·R Then, P Angehrn
Jan 1, 1974·Scandinavian Journal of Infectious Diseases·E BengtssonG Tunevall
Nov 1, 1973·The Journal of Infectious Diseases·S J SeligmanD Alcid
Sep 13, 1995·JAMA : the Journal of the American Medical Association·L LeiboviciS D Pitlik
Jul 1, 1994·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L JemniA Letaief
Mar 1, 1996·Infection·H M HasselhornF W Tiller
Apr 25, 1997·Journal of Molecular Biology·I C HampeleR L Then
Nov 18, 1997·British Journal of Nursing : BJN·S Hampton
Dec 24, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C von EiffG Peters
Dec 10, 1998·Journal of Internal Medicine·L LeiboviciS D Pitlik
Mar 19, 1999·Emerging Infectious Diseases·R J RubinA Moiduddin
Oct 19, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C GonzálezJ J Picazo
Nov 24, 1999·The Journal of Infectious Diseases·J N MartinJ L Gerberding
Dec 10, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C von EiffR A Proctor
May 8, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P Huovinen
May 8, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C von EiffG Peters
Jun 5, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J FortúnS Moreno
Dec 20, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sara E CosgroveYehuda Carmeli
Jun 25, 2003·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Graeme R NimmoUNKNOWN AGAR
Oct 2, 2003·Emerging Infectious Diseases·Jihad BisharaLeonard Leibovici
Jan 16, 2004·Scandinavian Journal of Infectious Diseases·Leonard B JohnsonRiad Khatib
Jan 27, 2004·The Annals of Pharmacotherapy·May Adra, Kenneth R Lawrence
Nov 1, 1950·The Australian Journal of Experimental Biology and Medical Science·F J MOSS, R LEMBERG
Apr 9, 2005·The New England Journal of Medicine·Henry F Chambers

❮ Previous
Next ❯

Citations

Jul 31, 2012·Current Infectious Disease Reports·Ilker UçkayDaniel Lew
Mar 9, 2010·Lancet·Frank R DeLeoHenry F Chambers
May 13, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J Carl CraftPrabhavathi Fernandes
Sep 27, 2008·The Pediatric Infectious Disease Journal·Pablo Yagupsky
Aug 6, 2011·The Pediatric Infectious Disease Journal·Allison F MessinaDavid M Berman
May 18, 2012·The Pediatric Infectious Disease Journal·Ilaria Pezone, Sebastiano Leone
Apr 14, 2010·Current Opinion in Pediatrics·Christine A Odell
Jan 18, 2012·Current Opinion in Infectious Diseases·Paula RamirezAntonio Torres
May 7, 2010·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Sandeep ChhabraJames D Swarbrick
Dec 24, 2009·Antimicrobial Agents and Chemotherapy·Johannes ZanderThomas A Wichelhaus
Mar 20, 2013·Journal of Clinical Microbiology·Michael S GelfandDaniel C Ketterer
Mar 20, 2013·Journal of Clinical Microbiology·Asha C BowenJonathan R Carapetis
Jan 26, 2012·PloS One·Sandeep ChhabraJames D Swarbrick
Apr 25, 2012·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·M M TeixeiraA G Oliveira
Feb 20, 2014·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·C Sunderkötter, K Becker
Sep 28, 2013·The Journal of Antimicrobial Chemotherapy·Baek-Nam KimMyoung-Don Oh
Jan 7, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Catherine LiuUNKNOWN Infectious Diseases Society of America
Dec 2, 2015·Journal of the Pediatric Infectious Diseases Society·Daniel EngelmanSteven Y C Tong
Oct 20, 2010·Expert Opinion on Pharmacotherapy·Solen Pichereau, Warren E Rose
Sep 9, 2010·The American Journal of the Medical Sciences·Karen K Kinney
Oct 15, 2010·The American Journal of the Medical Sciences·Huda A Bukharie
Mar 1, 2012·European Journal of Medicinal Chemistry·Martin KrátkýJiřina Stolaříková
Jul 26, 2011·Drug Discovery Today·Amy C AndersonNorton P Peet
Oct 16, 2010·International Journal of Antimicrobial Agents·Johannes ZanderThomas A Wichelhaus
Aug 21, 2010·International Journal of Antimicrobial Agents·Tobias Welte, Mathias W Pletz
Nov 17, 2009·Infectious Disease Clinics of North America·Susana Chavez-Bueno, Terrence L Stull
Aug 12, 2009·Infectious Disease Clinics of North America·David J RitchiePatrick M Finnegan
Jun 30, 2009·International Journal of Antimicrobial Agents·Ian M Gould
Feb 17, 2009·Diagnostic Microbiology and Infectious Disease·Ronald N JonesHelio S Sader
Jan 13, 2009·Infectious Disease Clinics of North America·Howard S Gold, Satish K Pillai
Nov 11, 2008·Disease-a-month : DM·Mark D Johnson, Catherine F Decker
Sep 20, 2011·Pharmacotherapy·Jason M PogueKeith S Kaye

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.